Net Deals Web Search

  1. Ads

    related to: cytokinetics als patients

Search results

  1. Results From The WOW.Com Content Network
  2. Cytokinetics - Wikipedia

    en.wikipedia.org/wiki/Cytokinetics

    Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.

  3. Motor neuron diseases - Wikipedia

    en.wikipedia.org/wiki/Motor_neuron_diseases

    Motor neuron diseases or motor neurone diseases ( MNDs) are a group of rare neurodegenerative disorders that selectively affect motor neurons, the cells which control voluntary muscles of the body. [1] [2] They include amyotrophic lateral sclerosis (ALS), [3] [4] progressive bulbar palsy (PBP), pseudobulbar palsy, progressive muscular atrophy ...

  4. Cytokinetics heart drug succeeds in closely watched study ...

    www.aol.com/news/cytokinetics-heart-disease-drug...

    Shares of the San Francisco-based Cytokinetics surged over 80% to touch a more than a 19-year high of $83.82, on track to add as much as $3.74 bi Cytokinetics heart drug succeeds in closely ...

  5. Lawrence S.B. Goldstein - Wikipedia

    en.wikipedia.org/wiki/Lawrence_S.B._Goldstein

    University of California, San Diego. Lawrence S.B. Goldstein (born February 20, 1956, in Buffalo, New York) is a professor of cellular and molecular medicine at University of California, San Diego and investigator with the Howard Hughes Medical Institute. [1] He receives grant funding from the NIH, the Johns Hopkins ALS Center, the HighQ ...

  6. Novartis in advanced talks to buy Cytokinetics- source - AOL

    www.aol.com/news/novartis-advanced-talks-buy...

    In late December, Cytokinetics' shares jumped over 82% after aficamten met the main goal of a keenly awaited late-stage study, putting it on track to compete with a rival treatment from Bristol ...

  7. ALS drug will be pulled from US market after study showed ...

    www.aol.com/news/als-drug-pulled-us-market...

    The Food and Drug Administration approved the much-debated drug, Relyvrio, in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS.

  8. Jamie Heywood - Wikipedia

    en.wikipedia.org/wiki/Jamie_Heywood

    Jamie Heywood. James Heywood (born October 4, 1966, in London, England) is an American MIT mechanical engineer who founded with his family the ALS Therapy Development Institute (ALS TDI) when his younger brother Stephen Heywood was diagnosed with amyotrophic lateral sclerosis (ALS) in December 1998. He is currently a director at AOBiome, as ...

  9. AOL Mail

    mail.aol.com

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

  1. Ads

    related to: cytokinetics als patients